Ibnate^®

Therapeutic Segment:
Bisphosphonates

Generic Name:
Ibandronate Sodium

Description:
IBNATE (Ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption.

Indication:
IBNATE (Ibandronic Acid) is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Formulation:

• Injection
• Tablets

Strength:

• Injection : 3mg/3ml
• Tablets : 150mg

Pack Size:

• Tablets : 1’s
• Injection : 1’s